CN104491672A - Traditional Chinese medicine preparation for treating chronic tracheitis and preparation method thereof - Google Patents
Traditional Chinese medicine preparation for treating chronic tracheitis and preparation method thereof Download PDFInfo
- Publication number
- CN104491672A CN104491672A CN201410827161.8A CN201410827161A CN104491672A CN 104491672 A CN104491672 A CN 104491672A CN 201410827161 A CN201410827161 A CN 201410827161A CN 104491672 A CN104491672 A CN 104491672A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 95
- 238000002360 preparation method Methods 0.000 title claims abstract description 56
- 206010044302 Tracheitis Diseases 0.000 title claims abstract description 26
- 241000218176 Corydalis Species 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000002775 capsule Substances 0.000 claims description 30
- 239000009636 Huang Qi Substances 0.000 claims description 25
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 25
- 241000244155 Taenia Species 0.000 claims description 24
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 16
- 238000005516 engineering process Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 3
- 244000183685 Citrus aurantium Species 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 240000000249 Morus alba Species 0.000 abstract description 2
- 235000008708 Morus alba Nutrition 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 241000432824 Asparagus densiflorus Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 240000006927 Foeniculum vulgare Species 0.000 abstract 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000000857 drug effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 29
- 239000000243 solution Substances 0.000 description 24
- 210000003734 kidney Anatomy 0.000 description 21
- 206010011224 Cough Diseases 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 16
- 206010036790 Productive cough Diseases 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 235000021251 pulses Nutrition 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 206010037660 Pyrexia Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 208000011580 syndromic disease Diseases 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 7
- 230000003419 expectorant effect Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 206010013781 dry mouth Diseases 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 206010029410 night sweats Diseases 0.000 description 5
- 230000036565 night sweats Effects 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000008506 pathogenesis Effects 0.000 description 5
- 206010013954 Dysphoria Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 208000037921 secondary disease Diseases 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010016029 Face oedema Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 230000004856 capillary permeability Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 210000005239 tubule Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 206010029446 nocturia Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical group [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000209128 Bambusa Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 244000218454 Bambusa tulda Species 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241001644290 Fritillaria unibracteata Species 0.000 description 1
- 241000967672 Gentiana crassicaulis Species 0.000 description 1
- 241000290619 Gentiana dahurica Species 0.000 description 1
- 241000501719 Gentiana straminea Species 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- 240000005827 Phyllostachys nigra Species 0.000 description 1
- 235000010717 Phyllostachys nigra Nutrition 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine preparation for treating chronic tracheitis and a preparation method thereof. The traditional Chinese medicine preparation comprises the following nineteen traditional Chinese medicine raw materials: astragalus, poria cocos, tendril-leaved fritillary bulb, corydalis tuber, fennel, platycodon grandiflorum, immature bitter orange, the root bark of white mulberry, caulis bambusae in taeniam, turtle shell, prepared rehmannia root, asparagus fern, rhizoma anemarrhenae, elecampane, mangnolia officinalis, cassia twig, fructus amomi, large-leaved gentian and liquorice. The traditional Chinese medicine preparation has the technical advantages such as fast effectiveness, good effect, effects of treating both symptoms and root causes and recuperating under medical treatment and difficulty in disease reoccurrence in the aspect of treating the chronic tracheitis, and particularly has an obvious effect of treating the severe and lingering chronic tracheitis. Moreover, the preparation process is simple and feasible, and the traditional Chinese medicine preparation is stable in drug effect, high in universality and easy for popularization and application.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of chronic tracheitis and preparation method thereof, belong to the field of Chinese medicines.
Background technology
The differentiation of symptoms and signs for classification of syndrome of the traditional Chinese medical science to chronic tracheitis is as follows:
1, insufficiency of lung-QI
Syndrome: (1), primary symptom: cough sound clear and bright often to cough for sick, mostly is cough only or interval is coughed, and daytime, amount of expectoration was few more than night.Body of the tongue is normal or slightly light, thin white fur of tongue.Stringy and thready pulse or slow thin.(2), secondary disease: easily antiperspirant, aversion to wind, easy catching a cold.
Discrimination: (1), dialectical: with cough with asthma, easily antiperspirant, easy catching a cold, pale tongue often, moderate pulse string or slow be carefully main dialectical main points.Face disease fashion and exterior syndrome distinguish or note with or without assorted exterior syndrome of holding concurrently.(2), pathogenesis: lung governing skin and hair, insufficiency of lung-QI is weakened defensive QI then, therefore easy catching a cold, spontaneous perspiration, aversion to wind, pale tongue with white fur, stringy and thready pulse or be slowly carefully resembling of the deficiency of vital energy.
2, deficiency of spleen-YANG
Syndrome: (1), primary symptom: disease sends out heavy cough often, mostly is and coughs repeatedly, heavy day at night is light, and cough mucus or starch and glue expectorant, amount of expectoration is often more.Pale tongue or fat, has indentation, and tongue fur is white or white thick greasy.Relaxed and soft pulse or cunning.(2), secondary disease: inappetence, after meal abdominal distention, face edema due to deficiency, large loose stool is soft.
Discrimination: (1), dialectical:, pale tongue soft with abundant expectoration, inappetence, face edema due to deficiency, loose stool or fatly have tooth to print, Tai Bai or greasy in vain, soft pulse is sliding or sliding is dialectical main points.Face card and still should note phlegm-damp degree.(2), pathogenesis: the lung being damaged by lasted cough, spleen YANG deficiency, spleen loses.Strong fortune, or raw in phlegm-damp, upper stain is in lung, and impairment of dispersing and descending function of the lung, therefore expectoration slurry is sticky, expectoration amount is many.Dysfunction of the spleen in transportation is inappetence then, after meal abdominal distention.Stagnation of damp caused by insufficiency of YANG is face edema due to deficiency then, and large loose stool is soft.Light red tongue is fat has tooth to print, tongue in vain then relaxed and soft pulse or sliding be deficiency of spleen-YANG it
3, insufficiency of kidney-YANG
Syndrome: (1), primary symptom: then breathe hard as feature with dynamic.It is puckery that disease coughs sound loud, high-pitched sound often, and mostly be apasm of coughing, night, amount of expectoration was many more than day.Pale tongue is fat or have the stasis of blood to resemble, and white and slippery fur moistens.Arteries and veins many thin (heavy thin, stringy and thready pulse, count accurately).(2), secondary disease: soreness of the loins and weakness of the limbs, cough the then enuresis, nocturia quite.Dizzy tinnitus, coldness of the body cold extremities, language of breathing hard is timid.
Syndrome: (1), dialectical: dynamicly then to breathe hard, to pant, amount of expectoration is many, soreness of the loins and weakness of the limbs, coldness of the body with chills, light red tongue are fat, white and slippery fur profit, thready pulse be for feature.(2), pathogenesis: kidney governing inspiration, it is breathed with row to help lung, and suffer from a deficiency of the kidney, it is timid with language of breathing hard that the gas of suction can not be contained in kidney under lung; Pant, breathing can not be connected, move and then pant.Kidney governing bones is had one's ideas straightened out in ear, and waist is the internal organs of kidney, then soreness of the loins and weakness of the limbs of suffering from a deficiency of the kidney, dizzy tinnitus, nocturia.The raw endogenous cold of yang deficiency, therefore coldness of the body cold extremities, pale tongue are fat or have the stasis of blood to resemble, white and slippery fur moistens, and how thin arteries and veins is, is resembling of insufficiency of kidney-YANG.
4, deficiency in both YIN and YANG
Syndrome: symptom: have dry mouth and throat concurrently on the basis of insufficiency of kidney-YANG, dysphoria with feverish sensation in the chest palms and soles, the deficiency of YIN symptoms such as hectic fever night sweat.Purple, the few tongue of corpulent tongue, color or no fur, often have the stasis of blood to resemble.Thready and rapid pulse.
Discrimination: (1), dialectical: on insufficiency of kidney-YANG basis, is doublely shown in dry mouth and throat, dysphoria with feverish sensation in the chest palms and soles, hectic fever night sweat, purple, the few tongue of colour of the tongue, deficient and rapid pulse.(2), pathogenesis: prolonged illness injures the moon, kidney yin loss, and body fluid can not go up lung moistening gold, therefore dry mouth and throat, and interior-heat is compeled Tianjin and gone out, then hectic fever night sweat.Enlarged tongue color purple resembling for yang deficiency.Due to interdependence between yin and yang, with the passing of time the deficiency of YIN, also must undermine yang-energy, and then becomes the card of deficiency of both YIN and YANG.
5, YIN-deficiency of the lung and kidney
Syndrome: (1), primary symptom: dry cough without phlegm or few expectorant, thick sputum is saloid grain, not easily expectoration.Normal moving then is breathed hard.The stripping of tongue fur light or few tongue, red tongue, thready and rapid pulse.(2), secondary disease: dry mouth and throat, dysphoria with feverish sensation in the chest palms and soles, hectic fever night sweat, has a dizzy spell, soreness of the loins and weakness of the limbs.
Discrimination: (1), dialectical: then breathe hard with dynamic, the few expectorant of dry cough, dry mouth and throat, soreness of the loins and weakness of the limbs, red tongue, few tongue, thready and rapid pulse is main points.(2), pathogenesis: deficiency of lung-YIN endogenous dryness, lung loses and moistens, so that respectful falling is had no right.Abnormal rising of lung-QI, kidney yin is deficient, and vital essence can not alternate.Gas does not return unit, therefore dynamic then breathes hard, and the few expectorant of dry cough, all cards such as dry mouth and throat grow.The deficiency of YIN raw interior-heat, then dysphoria with feverish sensation in the chest palms and soles hectic fever night sweat.Kidney yin is deficient, has a dizzy spell, soreness of the loins and weakness of the limbs, and the few tongue of red tongue, few Tianjin thready and rapid pulse is resembling of YIN-deficiency of the lung and kidney.
It is bad that prior art comprises the equal effect of the treatment of doctor trained in Western medicine to chronic tracheitis, and treatment cycle is long, weak effect, easily recurs.Chinese medicine preparation of the present invention takes into account each typing, scientific composition, practical proof, obtains one has good therapeutic effect Chinese medicine preparation to chronic tracheitis.
Summary of the invention
The technical problem to be solved in the present invention is a kind of Chinese medicine chronic tracheitis being had to better therapeutic effect of exploitation, and uses modern pharmaceutical technology that this Chinese medicine is made the required finished product preparation of modern clinic.
In order to solve the problems of the technologies described above, the technical scheme that inventor deals with problems is, according to the feature of modern pharmaceutical technology and tcm clinical practice experience for many years, and in chronic tracheitis years of researches, meticulous compatibility medical material, repeatedly adjusted, increased and decreased deal and the kind of crude drug by practice, the Chinese prescription that final invention one is brand-new, this Chinese prescription is (with parts by weight):
Radix Astragali 7-23 part, Poria 11-25 part, Bulbus Fritillariae Cirrhosae 14-26 part, Rhizoma Corydalis 8-20 part, Fructus Foeniculi 6-14 part, Radix Platycodonis 8-18 part, Fructus Aurantii Immaturus 5-15 part, Cortex Mori 7-15 part, Caulis Bambusae In Taenia 7-17 part, Carapax Trionycis 12-24 part, Radix Rehmanniae Preparata 11-21 part, Radix Asparagi 11-25 part, Rhizoma Anemarrhenae 6-14 part, Radix Aucklandiae 5-11 part, Cortex Magnoliae Officinalis 11-21 part, Ramulus Cinnamomi 6-16 part, Fructus Amomi 6-16 part, Radix Gentianae Macrophyllae 6-14 part, Radix Glycyrrhizae 7-15 part.
3 proportioning raw materials optimizing therapeutic effect best in prescription quantitative range are:
Proportioning 1: the Radix Astragali 15 parts, 18 parts, Poria, Bulbus Fritillariae Cirrhosae 20 parts, Rhizoma Corydalis 14 parts, 10 parts, Fructus Foeniculi, Radix Platycodonis 13 parts, Fructus Aurantii Immaturus 10 parts, Cortex Mori 11 parts, Caulis Bambusae In Taenia 12 parts, Carapax Trionycis 18 parts, Radix Rehmanniae Preparata 16 parts, Radix Asparagi 18 parts, the Rhizoma Anemarrhenae 10 parts, the Radix Aucklandiae 8 parts, Cortex Magnoliae Officinalis 16 parts, Ramulus Cinnamomi 11 parts, Fructus Amomi 11 parts, Radix Gentianae Macrophyllae 10 parts, 11 parts, Radix Glycyrrhizae.
Proportioning 2: the Radix Astragali 14 parts, 19 parts, Poria, Bulbus Fritillariae Cirrhosae 22 parts, Rhizoma Corydalis 13 parts, 11 parts, Fructus Foeniculi, Radix Platycodonis 12 parts, Fructus Aurantii Immaturus 12 parts, Cortex Mori 13 parts, Caulis Bambusae In Taenia 13 parts, Carapax Trionycis 16 parts, Radix Rehmanniae Preparata 15 parts, Radix Asparagi 17 parts, the Rhizoma Anemarrhenae 11 parts, the Radix Aucklandiae 10 parts, Cortex Magnoliae Officinalis 15 parts, Ramulus Cinnamomi 12 parts, Fructus Amomi 10 parts, Radix Gentianae Macrophyllae 11 parts, 12 parts, Radix Glycyrrhizae.
Proportioning 3: the Radix Astragali 16 parts, 20 parts, Poria, Bulbus Fritillariae Cirrhosae 19 parts, Rhizoma Corydalis 15 parts, 11 parts, Fructus Foeniculi, Radix Platycodonis 14 parts, Fructus Aurantii Immaturus 11 parts, Cortex Mori 12 parts, Caulis Bambusae In Taenia 13 parts, Carapax Trionycis 17 parts, Radix Rehmanniae Preparata 17 parts, Radix Asparagi 19 parts, the Rhizoma Anemarrhenae 11 parts, the Radix Aucklandiae 7 parts, Cortex Magnoliae Officinalis 17 parts, Ramulus Cinnamomi 10 parts, Fructus Amomi 12 parts, Radix Gentianae Macrophyllae 12 parts, 12 parts, Radix Glycyrrhizae.
The technique above-mentioned Chinese prescription being made preparation is following steps:
(1), each taste Chinese crude drug is taken by Chinese prescription of the present invention;
(2), by the Radix Astragali, Bulbus Fritillariae Cirrhosae, Fructus Aurantii Immaturus, Carapax Trionycis, Radix Rehmanniae Preparata, Radix Asparagi, Fructus Amomi, pulverize respectively, the concentration adding 7-11 times of weight after mixing is 65-75% ethanol, soaks 6-12 hour, backflow decocts, extract 2 times, each 2-5 hour, filter (reservation filtering residue), merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55-60 DEG C of relative density be the concentrated solution of 1.20-1.25, for subsequent use;
(3), Poria, Rhizoma Corydalis, Fructus Foeniculi, Radix Platycodonis, Cortex Mori, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Ramulus Cinnamomi, Radix Gentianae Macrophyllae, Radix Glycyrrhizae are pulverized respectively, with the purified water adding 6-9 times of weight after the filtering residue mixing of step (2), backflow decoction three times, each 1-3 hour, filter, merging filtrate, being concentrated into 55-60 DEG C of relative density is the concentrated solution of 1.20-1.25, for subsequent use;
(4), by concentrated solution obtained in step (2) and (3) merge, add Caulis Bambusae In Taenia, mix homogeneously, continuing to be evaporated to 55-60 DEG C of relative density is the thick paste of 1.30-1.35, is Chinese medical concrete;
(5), add suitable adjuvant, utilize modern general Chinese medicine preparation technology, step (4) gained Chinese medical concrete is made the Chinese medicine finished product preparation of clinical needs, as dosage forms such as tablet, pill, granule, capsule, oral liquid, powder, syrups.
The character feature of Chinese medicine preparation of the present invention Chinese crude drug used:
The Radix Astragali: this product is the dry root of leguminous plant Radix Astagali or Radix Astragali.Sweet in the mouth, warm in nature; Return lung, spleen channel; Invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.
Poria: this product is the dry sclerotia of On Polyporaceae Poria.Sweet in the mouth, light, property is put down; GUIXIN, spleen, kidney channel; Eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming.
Bulbus Fritillariae Cirrhosae: this product is the dry bulb of liliaceous plant Bulbus Fritillariae Cirrhosae, Fritillaria unibracteata, Gansu Bulbus Fritillariae Uninbracteatae or Bulbus Fritillariae cirrhosae.Bitter in the mouth, sweet, cold nature; Return lung, heart channel; Clearing heat and moistening lung, preventing phlegm from forming and stopping coughing.
Rhizoma Corydalis: this product is the dry tuber of papaveraceae plant corydalis.Acrid in the mouth, hardship, warm in nature; Return liver, spleen channel; Invigorate blood circulation, promoting the circulation of QI, pain relieving.
Fructus Foeniculi: be the fruit of samphire Fructus Foeniculi.Acrid in the mouth, warm in nature; Enter kidney, bladder, stomach warp; Warming kidney for dispelling cold, regulating the stomach to normalize QI.
Radix Platycodonis: this product is the dry root of Campanulaceae Radix Platycodonis.Bitter in the mouth, pungent, property is put down; Return lung meridian; Lung qi dispersing, sore-throat relieving, eliminates the phlegm, evacuation of pus.
Fructus Aurantii Immaturus: this product is the dry young fruit of rutaceae Citrus aurantium Linn. and variety or Fructus Citri sinensis.Bitter in the mouth, pungent, sour, warm in nature; Return spleen, stomach warp; Dispelling the stagnated QI removing food stagnancy, loose painful abdominal mass of reducing phlegm.
Cortex Mori: this product is the dry root bark of moraceae plants Mulberry.Sweet in the mouth, cold in nature; Return lung meridian; Eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema.
Caulis Bambusae In Taenia: this product is the dry intermediate layer of stem stalk of grass bambusa breviflora Munro, major part allusion quotation bamboo or phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle.Sweet in the mouth, cold nature; Attach to the lung and stomach meridians; Removing heat-phlegm, relieves restlessness and prevents vomiting.
Carapax Trionycis: this product is the carapace of Trionychidae animal Trionyx sinensis Wiegmann.Salty in the mouth, cold nature; Return liver, kidney channel; Nourishing YIN for suppressing the hyperactive YANG, hard masses softening and resolving, brings down a fever except steaming.
Radix Rehmanniae Preparata: this product is the Preparation process product of Radix Rehmanniae.Sweet in the mouth, slightly warm in nature; Return liver, kidney channel; Nourishing YIN and supplementing blood, beneficial essence fills out marrow.
Radix Asparagi: this product is the dried root of liliaceous plant Radix Asparagi.Sweet in the mouth, hardship, cold in nature; Return lung, kidney channel; Nourishing YIN to relieve dryness, lung heat clearing is promoted the production of body fluid.
The Rhizoma Anemarrhenae: this product is the dry rhizome of the liliaceous plant Rhizoma Anemarrhenae.Bitter in the mouth, sweet, cold in nature; Return lung, stomach, kidney channel; Clearing away heat-fire, promotes the production of body fluid and moisturizes.
The Radix Aucklandiae: this product is the dry root of the feverfew Radix Aucklandiae.Acrid in the mouth, hardship, warm in nature; Return spleen, stomach, large intestine, three burnt, gallbladder meridians; Promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion.
Cortex Magnoliae Officinalis: this product is the dry dried bark of Magnoliacea plant Cortex Magnoliae Officinalis or magnolia officinalis rehd.et wils.var.biloba rehd.et wils., root bark and branch skin.Bitter in the mouth, pungent, warm in nature; Return spleen, stomach, lung, large intestine channel; Dampness expectorant, the therapeutic method to keep the adverse QI flowing downwards is except full.
Ramulus Cinnamomi: this product is the dry twig of canella Cortex Cinnamomi.Acrid in the mouth, sweet, warm in nature; GUIXIN, lung, urinary bladder channel; Diaphoresis expelling pathogenic factors from muscles, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI, the flat gas that spins.
Fructus Amomi: this product is the dry mature fruit of zingiberaceous plant Fructus Amomi, green shell sand or SEMEN AMOMI LONGILIGULA.Acrid in the mouth, warm in nature; Return spleen, stomach, kidney channel; Removing dampness is whetted the appetite, warming spleen and stopping diarrha, regulates the flow of vital energy antiabortive.
Radix Gentianae Macrophyllae: this product is the dry root of gentianaceae plant Radix Gentianae Macrophyllae, gentiana straminea maxim, gentiana crassicaulis Duthie or Gentiana dahurica.Acrid in the mouth, hardship, property is put down; Return stomach, liver, gallbladder meridian; Wind-damp dispelling, clearing away damp-heat, stopping numbness pain.
Radix Glycyrrhizae: this product is the dry root of glycyrrhizic legume, Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L..Sweet in the mouth, property is put down; GUIXIN, lung, spleen, stomach warp; Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
The prescription analysis of Chinese prescription of the present invention:
Chinese prescription of the present invention is with Poria, Bulbus Fritillariae Cirrhosae, Carapax Trionycis, Radix Asparagi, Cortex Magnoliae Officinalis for monarch drug, and eliminating dampness and diuresis, clearing heat and moistening lung, nourishing YIN for suppressing the hyperactive YANG, lung heat clearing promote the production of body fluid, dampness expectorant; With the Radix Astragali, Rhizoma Corydalis, Radix Rehmanniae Preparata, Caulis Bambusae In Taenia, Radix Platycodonis for ministerial drug, invigorating QI to consolidate the body surface resistance, promoting the circulation of QI of invigorating blood circulation, nourishing YIN and supplementing blood, removing heat-phlegm, lung qi dispersing sore-throat relieving; With Cortex Mori, Fructus Aurantii Immaturus, Fructus Amomi, Ramulus Cinnamomi for adjuvant drug, inducing diuresis to remove edema, loose painful abdominal mass of reducing phlegm, removing dampness warming the spleen, promoting the flow of QI-blood by warming the meridian; With Fructus Foeniculi, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Radix Gentianae Macrophyllae for making medicine, warming kidney for dispelling cold, promote the production of body fluid moisturize, promoting the circulation of QI to relieve pain, dispel the wind wet clearly; With Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, all medicines are arranged in pairs or groups, synergism, jointly reach the effects such as clearing heat and moistening lung, dampness expectorant, lung qi dispersing sore-throat relieving, promoting the flow of QI-blood by warming the meridian, warming kidney for dispelling cold, have very significant therapeutic effect to chronic tracheitis.
Compared with prior art, Chinese medicine preparation of the present invention is in treatment chronic tracheitis, there is instant effect, effective, treating both the principal and secondary aspects of a disease, medical treatment combine, the not easily technical advantage such as recurrence, especially for cureless chronic tracheitis, there is therapeutic effect significantly, further, its preparation technology is simple and easy to do, preparation efficacy stability, universality are good, be easy to apply.
Detailed description of the invention
Embodiment 1
Produce by the maximum of the proportion of Chinese prescription of the present invention:
(1), Radix Astragali 23kg, Poria 25kg, Bulbus Fritillariae Cirrhosae 26kg, Rhizoma Corydalis 20kg, Fructus Foeniculi 14kg, Radix Platycodonis 18kg, Fructus Aurantii Immaturus 15kg, Cortex Mori 15kg, Caulis Bambusae In Taenia 17kg, Carapax Trionycis 24kg, Radix Rehmanniae Preparata 21kg, Radix Asparagi 25kg, Rhizoma Anemarrhenae 14kg, Radix Aucklandiae 11kg, Cortex Magnoliae Officinalis 21kg, Ramulus Cinnamomi 16kg, Fructus Amomi 16kg, Radix Gentianae Macrophyllae 14kg, Radix Glycyrrhizae 15kg is taken by Chinese prescription of the present invention;
(2), by the Radix Astragali, Bulbus Fritillariae Cirrhosae, Fructus Aurantii Immaturus, Carapax Trionycis, Radix Rehmanniae Preparata, Radix Asparagi, Fructus Amomi, pulverize respectively, the concentration adding 9 times of weight after mixing is 70% ethanol, soaks 10 hours, backflow decocts, extract 2 times, each 3 hours, filter (reservation filtering residue), merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55-60 DEG C of relative density be the concentrated solution of 1.20-1.25, for subsequent use;
(3), Poria, Rhizoma Corydalis, Fructus Foeniculi, Radix Platycodonis, Cortex Mori, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Ramulus Cinnamomi, Radix Gentianae Macrophyllae, Radix Glycyrrhizae are pulverized respectively, with the purified water adding 7 times of weight after the filtering residue mixing of step (2), backflow decoction three times, each 2 hours, filter, merging filtrate, being concentrated into 55-60 DEG C of relative density is the concentrated solution of 1.20-1.25, for subsequent use;
(4), by concentrated solution obtained in step (2) and (3) merge, add Caulis Bambusae In Taenia, mix homogeneously, continuing to be evaporated to 55-60 DEG C of relative density is the thick paste of 1.30-1.35, is Chinese medical concrete;
(5), add suitable adjuvant, utilize modern general Chinese medicine preparation technology, step (4) gained Chinese medical concrete is made capsule, and amounting to crude drug content is 1.08g crude drug/capsules.
Embodiment 2
Produce by the minima of the proportion of Chinese prescription of the present invention:
(1), Radix Astragali 7kg, Poria 11kg, Bulbus Fritillariae Cirrhosae 14kg, Rhizoma Corydalis 8kg, Fructus Foeniculi 6kg, Radix Platycodonis 8kg, Fructus Aurantii Immaturus 5kg, Cortex Mori 7kg, Caulis Bambusae In Taenia 7kg, Carapax Trionycis 12kg, Radix Rehmanniae Preparata 11kg, Radix Asparagi 11kg, Rhizoma Anemarrhenae 6kg, Radix Aucklandiae 5kg, Cortex Magnoliae Officinalis 11kg, Ramulus Cinnamomi 6kg, Fructus Amomi 6kg, Radix Gentianae Macrophyllae 6kg, Radix Glycyrrhizae 7kg is taken by Chinese prescription of the present invention;
(2), by the Radix Astragali, Bulbus Fritillariae Cirrhosae, Fructus Aurantii Immaturus, Carapax Trionycis, Radix Rehmanniae Preparata, Radix Asparagi, Fructus Amomi, pulverize respectively, the concentration adding 9 times of weight after mixing is 70% ethanol, soaks 10 hours, backflow decocts, extract 2 times, each 3 hours, filter (reservation filtering residue), merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55-60 DEG C of relative density be the concentrated solution of 1.20-1.25, for subsequent use;
(3), Poria, Rhizoma Corydalis, Fructus Foeniculi, Radix Platycodonis, Cortex Mori, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Ramulus Cinnamomi, Radix Gentianae Macrophyllae, Radix Glycyrrhizae are pulverized respectively, with the purified water adding 7 times of weight after the filtering residue mixing of step (2), backflow decoction three times, each 2 hours, filter, merging filtrate, being concentrated into 55-60 DEG C of relative density is the concentrated solution of 1.20-1.25, for subsequent use;
(4), by concentrated solution obtained in step (2) and (3) merge, add Caulis Bambusae In Taenia, mix homogeneously, continuing to be evaporated to 55-60 DEG C of relative density is the thick paste of 1.30-1.35, is Chinese medical concrete;
(5), add suitable adjuvant, utilize modern general Chinese medicine preparation technology, step (4) gained Chinese medical concrete is made capsule, and amounting to crude drug content is 1.08g crude drug/capsules.
Embodiment 3
Produce by the arbitrary value in the proportion of Chinese prescription of the present invention:
(1), Radix Astragali 23kg, Poria 11kg, Bulbus Fritillariae Cirrhosae 26kg, Rhizoma Corydalis 8kg, Fructus Foeniculi 14kg, Radix Platycodonis 8kg, Fructus Aurantii Immaturus 15kg, Cortex Mori 7kg, Caulis Bambusae In Taenia 17kg, Carapax Trionycis 12kg, Radix Rehmanniae Preparata 21kg, Radix Asparagi 11kg, Rhizoma Anemarrhenae 14kg, Radix Aucklandiae 5kg, Cortex Magnoliae Officinalis 21kg, Ramulus Cinnamomi 6kg, Fructus Amomi 16kg, Radix Gentianae Macrophyllae 6kg, Radix Glycyrrhizae 15kg is taken by Chinese prescription of the present invention;
(2), by the Radix Astragali, Bulbus Fritillariae Cirrhosae, Fructus Aurantii Immaturus, Carapax Trionycis, Radix Rehmanniae Preparata, Radix Asparagi, Fructus Amomi, pulverize respectively, the concentration adding 9 times of weight after mixing is 70% ethanol, soaks 10 hours, backflow decocts, extract 2 times, each 3 hours, filter (reservation filtering residue), merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55-60 DEG C of relative density be the concentrated solution of 1.20-1.25, for subsequent use;
(3), Poria, Rhizoma Corydalis, Fructus Foeniculi, Radix Platycodonis, Cortex Mori, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Ramulus Cinnamomi, Radix Gentianae Macrophyllae, Radix Glycyrrhizae are pulverized respectively, with the purified water adding 7 times of weight after the filtering residue mixing of step (2), backflow decoction three times, each 2 hours, filter, merging filtrate, being concentrated into 55-60 DEG C of relative density is the concentrated solution of 1.20-1.25, for subsequent use;
(4), by concentrated solution obtained in step (2) and (3) merge, add Caulis Bambusae In Taenia, mix homogeneously, continuing to be evaporated to 55-60 DEG C of relative density is the thick paste of 1.30-1.35, is Chinese medical concrete;
(5), add suitable adjuvant, utilize modern general Chinese medicine preparation technology, step (4) gained Chinese medical concrete is made capsule, and amounting to crude drug content is 1.08g crude drug/capsules.
Embodiment 4
Produce by the value of the optimum ratio 1 in the proportion of Chinese prescription of the present invention:
(1), Radix Astragali 15kg, Poria 18kg, Bulbus Fritillariae Cirrhosae 20kg, Rhizoma Corydalis 14kg, Fructus Foeniculi 10kg, Radix Platycodonis 13kg, Fructus Aurantii Immaturus 10kg, Cortex Mori 11kg, Caulis Bambusae In Taenia 12kg, Carapax Trionycis 18kg, Radix Rehmanniae Preparata 16kg, Radix Asparagi 18kg, Rhizoma Anemarrhenae 10kg, Radix Aucklandiae 8kg, Cortex Magnoliae Officinalis 16kg, Ramulus Cinnamomi 11kg, Fructus Amomi 11kg, Radix Gentianae Macrophyllae 10kg, Radix Glycyrrhizae 11kg is taken by Chinese prescription of the present invention;
(2), by the Radix Astragali, Bulbus Fritillariae Cirrhosae, Fructus Aurantii Immaturus, Carapax Trionycis, Radix Rehmanniae Preparata, Radix Asparagi, Fructus Amomi, pulverize respectively, the concentration adding 9 times of weight after mixing is 70% ethanol, soaks 10 hours, backflow decocts, extract 2 times, each 3 hours, filter (reservation filtering residue), merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55-60 DEG C of relative density be the concentrated solution of 1.20-1.25, for subsequent use;
(3), Poria, Rhizoma Corydalis, Fructus Foeniculi, Radix Platycodonis, Cortex Mori, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Ramulus Cinnamomi, Radix Gentianae Macrophyllae, Radix Glycyrrhizae are pulverized respectively, with the purified water adding 7 times of weight after the filtering residue mixing of step (2), backflow decoction three times, each 2 hours, filter, merging filtrate, being concentrated into 55-60 DEG C of relative density is the concentrated solution of 1.20-1.25, for subsequent use;
(4), by concentrated solution obtained in step (2) and (3) merge, add Caulis Bambusae In Taenia, mix homogeneously, continuing to be evaporated to 55-60 DEG C of relative density is the thick paste of 1.30-1.35, is Chinese medical concrete;
(5), add suitable adjuvant, utilize modern general Chinese medicine preparation technology, step (4) gained Chinese medical concrete is made capsule, and amounting to crude drug content is 1.08g crude drug/capsules.
Embodiment 5
Produce by the value of the optimum ratio 2 in the proportion of Chinese prescription of the present invention:
(1), Radix Astragali 14kg, Poria 19kg, Bulbus Fritillariae Cirrhosae 22kg, Rhizoma Corydalis 13kg, Fructus Foeniculi 11kg, Radix Platycodonis 12kg, Fructus Aurantii Immaturus 12kg, Cortex Mori 13kg, Caulis Bambusae In Taenia 13kg, Carapax Trionycis 16kg, Radix Rehmanniae Preparata 15kg, Radix Asparagi 17kg, Rhizoma Anemarrhenae 11kg, Radix Aucklandiae 10kg, Cortex Magnoliae Officinalis 15kg, Ramulus Cinnamomi 12kg, Fructus Amomi 10kg, Radix Gentianae Macrophyllae 11kg, Radix Glycyrrhizae 12kg is taken by Chinese prescription of the present invention;
(2), by the Radix Astragali, Bulbus Fritillariae Cirrhosae, Fructus Aurantii Immaturus, Carapax Trionycis, Radix Rehmanniae Preparata, Radix Asparagi, Fructus Amomi, pulverize respectively, the concentration adding 9 times of weight after mixing is 70% ethanol, soaks 10 hours, backflow decocts, extract 2 times, each 3 hours, filter (reservation filtering residue), merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55-60 DEG C of relative density be the concentrated solution of 1.20-1.25, for subsequent use;
(3), Poria, Rhizoma Corydalis, Fructus Foeniculi, Radix Platycodonis, Cortex Mori, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Ramulus Cinnamomi, Radix Gentianae Macrophyllae, Radix Glycyrrhizae are pulverized respectively, with the purified water adding 7 times of weight after the filtering residue mixing of step (2), backflow decoction three times, each 2 hours, filter, merging filtrate, being concentrated into 55-60 DEG C of relative density is the concentrated solution of 1.20-1.25, for subsequent use;
(4), by concentrated solution obtained in step (2) and (3) merge, add Caulis Bambusae In Taenia, mix homogeneously, continuing to be evaporated to 55-60 DEG C of relative density is the thick paste of 1.30-1.35, is Chinese medical concrete;
(5), add suitable adjuvant, utilize modern general Chinese medicine preparation technology, step (4) gained Chinese medical concrete is made capsule, and amounting to crude drug content is 1.08g crude drug/capsules.
Embodiment 6
Produce by the value of the optimum ratio 3 in the proportion of Chinese prescription of the present invention:
(1), Radix Astragali 16kg, Poria 20kg, Bulbus Fritillariae Cirrhosae 19kg, Rhizoma Corydalis 15kg, Fructus Foeniculi 11kg, Radix Platycodonis 14kg, Fructus Aurantii Immaturus 11kg, Cortex Mori 12kg, Caulis Bambusae In Taenia 13kg, Carapax Trionycis 17kg, Radix Rehmanniae Preparata 17kg, Radix Asparagi 19kg, Rhizoma Anemarrhenae 11kg, Radix Aucklandiae 7kg, Cortex Magnoliae Officinalis 17kg, Ramulus Cinnamomi 10kg, Fructus Amomi 12kg, Radix Gentianae Macrophyllae 12kg, Radix Glycyrrhizae 12kg is taken by Chinese prescription of the present invention;
(2), by the Radix Astragali, Bulbus Fritillariae Cirrhosae, Fructus Aurantii Immaturus, Carapax Trionycis, Radix Rehmanniae Preparata, Radix Asparagi, Fructus Amomi, pulverize respectively, the concentration adding 9 times of weight after mixing is 70% ethanol, soaks 10 hours, backflow decocts, extract 2 times, each 3 hours, filter (reservation filtering residue), merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55-60 DEG C of relative density be the concentrated solution of 1.20-1.25, for subsequent use;
(3), Poria, Rhizoma Corydalis, Fructus Foeniculi, Radix Platycodonis, Cortex Mori, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Ramulus Cinnamomi, Radix Gentianae Macrophyllae, Radix Glycyrrhizae are pulverized respectively, with the purified water adding 7 times of weight after the filtering residue mixing of step (2), backflow decoction three times, each 2 hours, filter, merging filtrate, being concentrated into 55-60 DEG C of relative density is the concentrated solution of 1.20-1.25, for subsequent use;
(4), by concentrated solution obtained in step (2) and (3) merge, add Caulis Bambusae In Taenia, mix homogeneously, continuing to be evaporated to 55-60 DEG C of relative density is the thick paste of 1.30-1.35, is Chinese medical concrete;
(5), add suitable adjuvant, utilize modern general Chinese medicine preparation technology, step (4) gained Chinese medical concrete is made capsule, and amounting to crude drug content is 1.08g crude drug/capsules.
Embodiment 7
Embodiment of the present invention 1-6 produce the animal toxicity test of capsule
(1) test drug: the capsule obtained by embodiment of the present invention 1-6, abolishes capsule shells, adds purified water and is modulated into solution.Test animal used: regular grade NIH mice, body weight 24g ± 3g, male and female half and half, female mice is all without pregnant; SD rat, original body mass 223 ± 8g, male and female half and half, female rats is all without pregnant.
(2) acute toxicity test
Application mice carries out acute toxicity testing and shows: mouse stomach By Chinese Medicines of the present invention, under 752.2g crude drug/kg dosage, after administration, mice occurs that light activity reduces, 2 hours recover normal, Continuous Observation 7 days after administration, none dead mouse, and overall health of patients, diet, take the photograph water, urine and body weight increase all normal.Experimental result shows: the maximum dosage-feeding of mouse stomach Chinese medicine oral liquid of the present invention is 752.2g crude drug/kg/d(LD
50> 752.2g crude drug/kg).Chinese medicine preparation clinical application every day total amount of the present invention is 0.18g crude drug/kg/d; By weighing machine, the dosis tolerata of mouse stomach Chinese medicine preparation of the present invention is 4178.9 times of clinical patient.Point out this medicine acute toxicity extremely low, clinical drug safety.
(3), long term toxicity test
Select SD rat, give the By Chinese Medicines of the present invention of Three doses: 32.4g crude drug/kg, 10.8g crude drug/kg, 3.6g crude drug/kg(per weight dosage is by 20 times of calculating of clinical application amount, and clinical application amount is according to Pharmacopoeia of the People's Republic of China version in 2010).Every day gavage once, continuous 90 days, after last administration 24 hours respectively group live and kill 1/2 animal (male and female half and half), all the other 1/2 animals continue that observations are alive after 2 weeks kills.Duration of test observes outward appearance, general behavior, food ration, the body weight change of animal; Within after administration 90 days, within 2 weeks, carry out the index checking such as hematology's (RBC, HB, reticulocyte, PLT, CT, WBC and classification) and blood biochemical (AST, ALT, ALP, Glu, BUN, Crea, TP, T.BIL, ALB, CHOL), urine biochemistry, organ coefficient, histopathology with drug withdrawal.
Result of the test shows: Chinese medicine preparation of the present invention is good at high, medium and low dosage treated animal general state, and outward appearance sign, behavioral activity, food-intake and body weight increase change all without exception; Three dosage groups and matched group hematological examination, blood biochemical analysis, urine biochemical analysis all in normal range, without significant difference between group; Each group of main organs histopathological examination shows no obvious abnormalities.These parameters drug withdrawal also had no change after 2 weeks.This test dosage is respectively 180,60,20 times of clinical medicine dose, according to result of the test: Chinese medicine preparation of the present invention has no significant effect rat in high, medium and low three dosage (32.4g crude drug/kg, 10.8g crude drug/kg, 3.6g crude drug/kg) administration in continuous 90 days, without clear and definite toxicity target organ and sensitive indicator, convalescent period observation also has no retardance toxic reaction, points out the dose safety of Chinese medicine preparation clinical practice of the present invention very high.
Embodiment 8
The animal test of pesticide effectiveness of Chinese medicine preparation of the present invention
1, trial drug
Embodiment of the present invention 4-6(produces by 3 optimum ratios) made capsule, amounting to crude drug content is 1.08g crude drug/capsules, abolishes capsule shells, adds purified water and be modulated into solution.
2, laboratory animal
Kunming mouse, body weight 19g ± 3g, male and female half and half, female mice is all without pregnant; SD rat, original body mass 223 ± 8g, male and female half and half, female rats is all without pregnant.
3, test method
(1), Chinese medicine preparation of the present invention is on the impact of mouse peritoneal capillary permeability
Get Kunming mouse 80, male and female half and half, be divided into 8 groups, often organize 10.Administration: blank group (isometric(al) distilled water), aspirin group (0.2g/kg), embodiment 4-6 group gives the capsule of two dosage respectively, 10 times of low dosage to be crude drug amount that 1.8g/kg/d(amounts to be clinical application), 20 times of high dose to be crude drug amount that 3.6g/kg/d(amounts to be clinical application).Each group of mice is with 20mL/kg gastric infusion, after administration, 1h vein injects 0.5% azovan blue normal saline solution 0.1ml/10g body weight, the acetic acid of lumbar injection 0.7% immediately, 0.2ml/ only, after 20min, mice is taken off cervical vertebra to put to death, abdominal cut integumentary musculature, divide with 10ml normal saline and wash abdominal cavity for several times, draw cleaning mixture and be incorporated into 10ml, 3000 revs/min of centrifugal 15min; Get supernatant 752 type spectrophotometers in its absorbance of 590nm place colorimetric determination, carry out statistical procedures with t inspection, the results are shown in Table 1.
Table 1 Chinese medicine preparation on the impact (n=10) of mouse peritoneal capillary permeability (
± SD)
Note: compare with blank group, * P<0.05, * * P<0.01.
Result shows, and the made capsule of embodiment 4-6 all can extremely significantly reduce mouse peritoneal capillary permeability, shows that the made capsule of embodiment 4-6 all has certain antiinflammatory action, and the proportioning performance of embodiment 5 is particularly outstanding.
(2), Chinese medicine preparation of the present invention is on the impact of Hair of Rat tubule expectoration amount
Get SD rat 80, be divided into 8 groups at random, often organize 10, male and female half and half.Administration: blank group (isometric(al) distilled water), ammonium chloride group (1g/kg), embodiment 4-6 group gives the capsule of two dosage respectively, 10 times of low dosage to be crude drug amount that 1.8g/kg/d(amounts to be clinical application), 20 times of high dose to be crude drug amount that 3.6g/kg/d(amounts to be clinical application), each group rat is with 10mL/kg gastric infusion; Each treated animal 30min upon administration, with 1g/kg urethane intraperitoneal injection of anesthesia, faces upward position and fixes; Cut off skin in the middle part of neck, isolate trachea, hit exactly between two cartilaginous rings at thyroid cartilage lower edge and prick an aperture with sharp-pointed injection needle, insert capillary glass tube one, make capillary tube just contact organ lower surface, so as to drawing the sputum at trachea rear portion; When being full of by sputum in capillary tube, separately change one immediately; Sputum length is drawn as the effect of reducing phlegm evaluating medicine using capillary tube; After the record administration normal secretions amount of first 2 hours, gastric infusion, continues to observe 2h secretory volume again; Relatively administration forward backward averaging secretory volume per hour, carries out statistical procedures with t inspection, the results are shown in Table 2.
Table 2 Chinese medicine preparation of the present invention on the impact (n=10) of Hair of Rat tubule expectoration amount (
± SD)
Note: compare with blank group, * P<0.05, * * P<0.01.
Result shows, and the made capsule of embodiment 4-6 all obviously can increase Hair of Rat tubule expectoration amount, and embodiment 5 is particularly evident; Show that the made capsule of embodiment 4-6 has good phlegm-dispelling functions.
Embodiment 9
The clinical trial of Chinese medicine preparation of the present invention
1, physical data
Experimenter of this test for 140, provides by certain the People's Hospital of city second, age 25-67 year, wherein man 79, female 61, all experimenters are all made a definite diagnosis by hospital suffers from chronic tracheitis, average course of disease 3.2 years.
2, trial drug
The made capsule of the embodiment of the present invention 5 (because it shows the most excellent in zoopery), amounting to crude drug content is 1.08g crude drug/capsules.
3, test method
The made capsule of the oral embodiment of the present invention of all experimenters 5, every day 2 times, each 5,4 is a course for the treatment of, treats 3 courses for the treatment of continuously.
4, the standard of curative effect evaluation
Cure: all symptoms of chronic tracheitis disappear completely, and make a definite diagnosis rehabilitation through doctor;
Effective: the symptom of chronic tracheitis has improvement in various degree, but still needs continual cure;
Invalid: the symptom of chronic tracheitis is without any improvement or take a turn for the better, even more serious;
Recurrence: the patient of healing again suffers from original disease in 6 months after stopping administration.
5, therapeutic outcome statistical analysis
Have 7 routine patients to come off in therapeutic process, have 133 routine patients and complete whole experiment, do not have the routine untoward reaction of appearance one, after test all completes, test data statistical analysis is in table 3.
Table 3 test data statistical analysis table
Complete example | Cure (rate) | Effective | Invalid | Total effective rate | Recurrence (rate) |
133 | 51(38.3%) | 74 | 8 | 94.0% | 4(7.8%) |
6, conclusion
Test data shows, and capsule of the present invention is 38.3% to the cure rate of chronic tracheitis, and total effective rate is up to 94.0%, and relapse rate is only 7.8%, therefore, Chinese medicine preparation of the present invention has very significant technical advantage for the treatment of chronic tracheitis, achieves beat all technological achievement.
Claims (6)
1. treat a Chinese medicine preparation for chronic tracheitis, it is characterized in that, the Chinese prescription of described Chinese medicine preparation is (with parts by weight):
Radix Astragali 7-23 part, Poria 11-25 part, Bulbus Fritillariae Cirrhosae 14-26 part, Rhizoma Corydalis 8-20 part, Fructus Foeniculi 6-14 part, Radix Platycodonis 8-18 part, Fructus Aurantii Immaturus 5-15 part, Cortex Mori 7-15 part, Caulis Bambusae In Taenia 7-17 part, Carapax Trionycis 12-24 part, Radix Rehmanniae Preparata 11-21 part, Radix Asparagi 11-25 part, Rhizoma Anemarrhenae 6-14 part, Radix Aucklandiae 5-11 part, Cortex Magnoliae Officinalis 11-21 part, Ramulus Cinnamomi 6-16 part, Fructus Amomi 6-16 part, Radix Gentianae Macrophyllae 6-14 part, Radix Glycyrrhizae 7-15 part.
2. a kind of Chinese medicine preparation for the treatment of chronic tracheitis according to claim 1, is characterized in that, the Chinese prescription of described Chinese medicine preparation is preferably (with parts by weight):
The Radix Astragali 15 parts, 18 parts, Poria, Bulbus Fritillariae Cirrhosae 20 parts, Rhizoma Corydalis 14 parts, 10 parts, Fructus Foeniculi, Radix Platycodonis 13 parts, Fructus Aurantii Immaturus 10 parts, Cortex Mori 11 parts, Caulis Bambusae In Taenia 12 parts, Carapax Trionycis 18 parts, Radix Rehmanniae Preparata 16 parts, Radix Asparagi 18 parts, the Rhizoma Anemarrhenae 10 parts, the Radix Aucklandiae 8 parts, Cortex Magnoliae Officinalis 16 parts, Ramulus Cinnamomi 11 parts, Fructus Amomi 11 parts, Radix Gentianae Macrophyllae 10 parts, 11 parts, Radix Glycyrrhizae.
3. a kind of Chinese medicine preparation for the treatment of chronic tracheitis according to claim 1, is characterized in that, the Chinese prescription of described Chinese medicine preparation is preferably (with parts by weight):
The Radix Astragali 14 parts, 19 parts, Poria, Bulbus Fritillariae Cirrhosae 22 parts, Rhizoma Corydalis 13 parts, 11 parts, Fructus Foeniculi, Radix Platycodonis 12 parts, Fructus Aurantii Immaturus 12 parts, Cortex Mori 13 parts, Caulis Bambusae In Taenia 13 parts, Carapax Trionycis 16 parts, Radix Rehmanniae Preparata 15 parts, Radix Asparagi 17 parts, the Rhizoma Anemarrhenae 11 parts, the Radix Aucklandiae 10 parts, Cortex Magnoliae Officinalis 15 parts, Ramulus Cinnamomi 12 parts, Fructus Amomi 10 parts, Radix Gentianae Macrophyllae 11 parts, 12 parts, Radix Glycyrrhizae.
4. a kind of Chinese medicine preparation for the treatment of chronic tracheitis according to claim 1, is characterized in that, the Chinese prescription of described Chinese medicine preparation is preferably (with parts by weight):
The Radix Astragali 16 parts, 20 parts, Poria, Bulbus Fritillariae Cirrhosae 19 parts, Rhizoma Corydalis 15 parts, 11 parts, Fructus Foeniculi, Radix Platycodonis 14 parts, Fructus Aurantii Immaturus 11 parts, Cortex Mori 12 parts, Caulis Bambusae In Taenia 13 parts, Carapax Trionycis 17 parts, Radix Rehmanniae Preparata 17 parts, Radix Asparagi 19 parts, the Rhizoma Anemarrhenae 11 parts, the Radix Aucklandiae 7 parts, Cortex Magnoliae Officinalis 17 parts, Ramulus Cinnamomi 10 parts, Fructus Amomi 12 parts, Radix Gentianae Macrophyllae 12 parts, 12 parts, Radix Glycyrrhizae.
5. a kind of Chinese medicine preparation for the treatment of chronic tracheitis according to claim 1, is characterized in that, the preparation technology of described Chinese medicine preparation is following steps:
Step (1), take each taste Chinese crude drug by Chinese prescription of the present invention;
Step (2), by the Radix Astragali, Bulbus Fritillariae Cirrhosae, Fructus Aurantii Immaturus, Carapax Trionycis, Radix Rehmanniae Preparata, Radix Asparagi, Fructus Amomi, pulverize respectively, the concentration adding 7-11 times of weight after mixing is 65-75% ethanol, soaks 6-12 hour, backflow decocts, extract 2 times, each 2-5 hour, filter (reservation filtering residue), merging filtrate, distilling under reduced pressure removing ethanol, and to be concentrated into 55-60 DEG C of relative density be the concentrated solution of 1.20-1.25, for subsequent use;
Step (3), Poria, Rhizoma Corydalis, Fructus Foeniculi, Radix Platycodonis, Cortex Mori, the Rhizoma Anemarrhenae, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Ramulus Cinnamomi, Radix Gentianae Macrophyllae, Radix Glycyrrhizae to be pulverized respectively, with the purified water adding 6-9 times of weight after the filtering residue mixing of step (2), backflow decoction three times, each 1-3 hour, filter, merging filtrate, being concentrated into 55-60 DEG C of relative density is the concentrated solution of 1.20-1.25, for subsequent use;
Step (4), the concentrated solution merging will obtained in step (2) and (3), add Caulis Bambusae In Taenia, mix homogeneously, continuing to be evaporated to 55-60 DEG C of relative density is the thick paste of 1.30-1.35, is Chinese medical concrete;
Step (5), add suitable adjuvant, utilize modern general Chinese medicine preparation technology, step (4) gained Chinese medical concrete is made the Chinese medicine finished product preparation of clinical needs.
6. a kind of Chinese medicine preparation for the treatment of chronic tracheitis according to claim 1, it is characterized in that, described Chinese medicine preparation can make tablet, pill, granule, capsule, oral liquid, powder and syrup.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410827161.8A CN104491672A (en) | 2014-12-29 | 2014-12-29 | Traditional Chinese medicine preparation for treating chronic tracheitis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410827161.8A CN104491672A (en) | 2014-12-29 | 2014-12-29 | Traditional Chinese medicine preparation for treating chronic tracheitis and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491672A true CN104491672A (en) | 2015-04-08 |
Family
ID=52933186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410827161.8A Pending CN104491672A (en) | 2014-12-29 | 2014-12-29 | Traditional Chinese medicine preparation for treating chronic tracheitis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491672A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815233A (en) * | 2015-05-25 | 2015-08-05 | 苗怡文 | Traditional Chinese medicine preparation for treating tuberculosis and preparation method thereof |
CN104825973A (en) * | 2015-05-25 | 2015-08-12 | 苗怡文 | Traditional Chinese medicine preparation for treating chronic dyspepsia and preparation method of traditional Chinese medicine prepration |
CN104826076A (en) * | 2015-05-27 | 2015-08-12 | 苗怡文 | Traditional Chinese medicine preparation for treating cough during pregnancy and preparation method thereof |
CN105497783A (en) * | 2015-12-21 | 2016-04-20 | 暨南大学 | Application of traditional Chinese medicine preparation to preparing drug for treating qi stagnation and blood stasis type chloasma |
-
2014
- 2014-12-29 CN CN201410827161.8A patent/CN104491672A/en active Pending
Non-Patent Citations (2)
Title |
---|
买雯婷: "《二十四节气药膳大全集》", 31 January 2011, 湖南美术出版社 * |
蔡向红: "《生活中来的10000个窍门》", 31 March 2014, 天津科学技术出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815233A (en) * | 2015-05-25 | 2015-08-05 | 苗怡文 | Traditional Chinese medicine preparation for treating tuberculosis and preparation method thereof |
CN104825973A (en) * | 2015-05-25 | 2015-08-12 | 苗怡文 | Traditional Chinese medicine preparation for treating chronic dyspepsia and preparation method of traditional Chinese medicine prepration |
CN104826076A (en) * | 2015-05-27 | 2015-08-12 | 苗怡文 | Traditional Chinese medicine preparation for treating cough during pregnancy and preparation method thereof |
CN105497783A (en) * | 2015-12-21 | 2016-04-20 | 暨南大学 | Application of traditional Chinese medicine preparation to preparing drug for treating qi stagnation and blood stasis type chloasma |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104491801A (en) | Traditional Chinese medicine preparation for treating acute or chronic gastritis and preparation method thereof | |
CN104940509A (en) | Application of medicine composition in preparing medicine for treating gynecology hemorrhage syndrome | |
CN104491672A (en) | Traditional Chinese medicine preparation for treating chronic tracheitis and preparation method thereof | |
CN104491802A (en) | Application of traditional Chinese medicine preparation in preparation of medicine for treating acute or chronic gastritis | |
CN104352793A (en) | Traditional Chinese medicine preparation for treating gastrointestinal bleeding and preparation method thereof | |
CN104491733A (en) | Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation | |
CN104306891A (en) | Traditional Chinese medicine for treating neurasthenia | |
CN104491798A (en) | Traditional Chinese medicine preparation for treating intestinal parasites and preparation process thereof | |
CN104491236A (en) | Traditional Chinese medicine preparation for treating essential hypertension and preparation method for traditional Chinese medicine preparation | |
CN105311470A (en) | Application of pharmaceutical composition containing folium artemisiae argyi in preparing medicine for treating diabetic nephropathy | |
CN104547859A (en) | Application of traditional Chinese medicine preparation in preparation of medicine for treating chronic tracheitis | |
CN104435567A (en) | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout | |
CN104721629B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of iron Deficiency Anemia | |
CN104826076A (en) | Traditional Chinese medicine preparation for treating cough during pregnancy and preparation method thereof | |
CN104645080A (en) | Traditional Chinese medicine preparation for treating dizziness and preparation method of traditional Chinese medicine preparation | |
CN105250968A (en) | Traditional Chinese medicine preparation for treating asthma | |
CN106177651A (en) | A kind of infantile malnutrition medicine | |
CN104840902A (en) | Traditional Chinese medicine preparation for treating ovarian tumor | |
CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
CN104491318A (en) | Traditional Chinese preparation used for treating asthma and preparation method of traditional Chinese preparation | |
CN104225004B (en) | A kind of adjunct antineoplastic Chinese medicine preparation containing pfaffia | |
CN104491490A (en) | Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof | |
CN104491344A (en) | Use of traditional Chinese medicine preparation in preparing medicines for treating bulging, red, swelling and pain symptoms of eyes | |
CN104826072A (en) | Traditional Chinese medicine preparation for treating respiratory system infection and preparation method of traditional Chinese medicine preparation | |
CN105749044A (en) | Chinese herb preparation for treating chronic nephritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |